These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17298352)

  • 41. Allergenic products standardization--the role of major allergens.
    Helm RM; Burks AW
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):164-73. PubMed ID: 9383906
    [No Abstract]   [Full Text] [Related]  

  • 42. Anaphylaxis caused by allergen sublingual immunotherapy?
    André C; Fadel R
    Allergy; 2007 Oct; 62(10):1220-1. PubMed ID: 17845597
    [No Abstract]   [Full Text] [Related]  

  • 43. Allergen injection immunotherapy (hyposensitization) on trial.
    Kay AB
    Clin Exp Allergy; 1989 Nov; 19(6):591-6. PubMed ID: 2598099
    [No Abstract]   [Full Text] [Related]  

  • 44. Safe allergen immunotherapy. The correct allergen, the appropriate patient, the adequate dose.
    Schoenwetter WF
    Postgrad Med; 1996 Aug; 100(2):123-6, 131-5. PubMed ID: 8700812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The safety of initiating Hymenoptera immunotherapy at 1 microg of venom extract.
    Roumana A; Pitsios C; Vartholomaios S; Kompoti E; Kontou-Fili K
    J Allergy Clin Immunol; 2009 Aug; 124(2):379-81. PubMed ID: 19560804
    [No Abstract]   [Full Text] [Related]  

  • 46. Development of polymerized allergens for immunotherapy.
    Grammer LC; Patterson R
    Asian Pac J Allergy Immunol; 1983 Jun; 1(1):55-8. PubMed ID: 6681109
    [No Abstract]   [Full Text] [Related]  

  • 47. Immunotherapy preparation guidelines, rules, and regulation.
    Esch RE; Plunkett GA
    Curr Allergy Asthma Rep; 2013 Aug; 13(4):406-13. PubMed ID: 23722699
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The LOCAL Study: Local reactions do not predict local reactions in allergen immunotherapy.
    Calabria CW; Coop CA; Tankersley MS
    J Allergy Clin Immunol; 2009 Oct; 124(4):739-44. PubMed ID: 19767075
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comment on the article: Hyposensitization therapy--quo vadis?].
    Kompa HE
    Z Hautkr; 1990 Jul; 65(7):645-6. PubMed ID: 2399755
    [No Abstract]   [Full Text] [Related]  

  • 50. Issues in stinging insect allergy immunotherapy: a review.
    Finegold I
    Curr Opin Allergy Clin Immunol; 2008 Aug; 8(4):343-7. PubMed ID: 18596592
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current standards and future directions in immunotherapy: perspectives on challenges and opportunities for the allergist.
    Bernstein DI; Blaiss MS; Cox LS; Finegold I; Lanier BQ; Nelson HS; Wallace DV
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):422-5. PubMed ID: 22018613
    [No Abstract]   [Full Text] [Related]  

  • 52. Relief for patients with severe allergies.
    Putman H; May KR
    RN; 2001 Jun; 64(6):26-30; quiz 31. PubMed ID: 12032929
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unproven and controversial forms of immunotherapy.
    Terr AI; Tcheurekdjian H
    Clin Allergy Immunol; 2008; 21():447-53. PubMed ID: 18828522
    [No Abstract]   [Full Text] [Related]  

  • 54. [Status of allergen immunotherapy in the treatment of allergic diseases].
    Okano M
    Arerugi; 2006 Jan; 55(1):22-7. PubMed ID: 16671327
    [No Abstract]   [Full Text] [Related]  

  • 55. Recombinant allergen-based concepts for diagnosis and therapy of type I allergy.
    Valenta R
    Allergy; 2002; 57 Suppl 71():66-7. PubMed ID: 12173274
    [No Abstract]   [Full Text] [Related]  

  • 56. Advantages and disadvantages of accelerated immunotherapy schedules.
    Cox L
    J Allergy Clin Immunol; 2008 Aug; 122(2):432-4. PubMed ID: 18619664
    [No Abstract]   [Full Text] [Related]  

  • 57. [Allergen extracts. New principles and time indicated products].
    Aas K
    Tidsskr Nor Laegeforen; 1977 Dec; 97(34-36):1809-11. PubMed ID: 594989
    [No Abstract]   [Full Text] [Related]  

  • 58. Allergen immunotherapy in historical perspective.
    Cohen SG; Richard E
    Clin Allergy Immunol; 2008; 21():1-29. PubMed ID: 18828495
    [No Abstract]   [Full Text] [Related]  

  • 59. Subcutaneous administration of allergen vaccines.
    Radtke M; Grammer LC
    Clin Allergy Immunol; 2008; 21():321-32. PubMed ID: 18828514
    [No Abstract]   [Full Text] [Related]  

  • 60. Allergen immunotherapy: the scientific facts.
    Gaur SN
    Indian J Chest Dis Allied Sci; 2011; 53(4):205-6. PubMed ID: 22128617
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.